SF
RPRX icon

Synovus Financial’s Royalty Pharma RPRX Stock Holding History

Synovus Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.84M Sell
80,581
-1,337
-2% -$48.4K 0.03% 294
2025
Q2 		$2.95M Sell
81,918
-1,574
-2% -$52.1K 0.04% 279
2025
Q1 		$2.6M Buy
83,492
+64,573
+341% +$2.05M 0.03% 293
2024
Q4 		$483K Sell
18,919
-85,378
-82% -$2.26M 0.01% 653
2024
Q3 		$2.95M Sell
104,297
-118,379
-53% -$3.28M 0.03% 319
2024
Q2 		$5.87M Buy
222,676
+111,918
+101% +$3.1M 0.08% 160
2024
Q1 		$3.36M Buy
110,758
+1,049
+1% +$30.9K 0.04% 257
2023
Q4 		$3.08M Sell
109,709
-10,032
-8% -$276K 0.04% 250
2023
Q3 		$3.25M Buy
119,741
+24,721
+26% +$734K 0.04% 251
2023
Q2 		$2.92M Sell
95,020
-4,149
-4% -$141K 0.03% 280
2023
Q1 		$3.57M Buy
99,169
+6,174
+7% +$229K 0.04% 235
2022
Q4 		$3.68M Buy
92,995
+1,566
+2% +$65.4K 0.04% 229
2022
Q3 		$3.68M Buy
91,429
+1,717
+2% +$73.3K 0.05% 209
2022
Q2 		$3.77M Buy
89,712
+8,663
+11% +$355K 0.04% 213
2022
Q1 		$3.16M Sell
81,049
-2,801
-3% -$110K 0.03% 253
2021
Q4 		$3.34M Buy
+83,850
New +$3.26M 0.03% 251

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Synovus Financial's RPRX Position: Q3 2025 in Review

Synovus Financial reduced its Royalty Pharma (RPRX) stake by 1.6% in Q3 2025, selling an estimated $48.4K and leaving 80,581 shares worth $2.84M. The position accounts for 0.03% of the portfolio, ranked #294.

Synovus Financial first reported a position in RPRX in Q4 2021 and has held it in 16 quarters since. The position peaked at $5.87M in Q2 2024. 487 funds tracked by Wall St. Rank hold RPRX as of Q3 2025.

  • Synovus Financial held 80,581 shares of Royalty Pharma worth $2.84M as of Q3 2025.
  • Synovus Financial sold 1,337 Royalty Pharma shares in Q3 2025, an estimated $48.4K.
  • Royalty Pharma made up 0.03% of Synovus Financial's portfolio in Q3 2025, its #294 holding.
  • Synovus Financial first reported a position in Royalty Pharma in Q4 2021 and has held it in 16 quarters since.
  • Synovus Financial's Royalty Pharma position peaked at $5.87M in Q2 2024.
  • 487 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.